Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 3 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
xuanping zhang
(158 results)?
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients.
Eur J Hosp Pharm. 2023 Mar;30(e1):e90-e96. doi: 10.1136/ejhpharm-2022-003357. Epub 2022 Jul 4.
Eur J Hosp Pharm. 2023.
PMID: 35787526
Free PMC article.
Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method.
Tian JC, Zhang XL, Cui JR, Li XG.
Tian JC, et al.
Curr Med Sci. 2022 Aug;42(4):863-870. doi: 10.1007/s11596-022-2596-2. Epub 2022 Jun 8.
Curr Med Sci. 2022.
PMID: 35678908
Free PMC article.
Item in Clipboard
Population pharmacokinetics of sirolimus in Chinese adult liver transplant recipients: a retrospective study.
Zhang Y, Zhang X, Zou Y, Sun Y, Li X.
Zhang Y, et al. Among authors: zhang x.
Xenobiotica. 2021 Dec;51(12):1408-1415. doi: 10.1080/00498254.2022.2025628. Epub 2022 Jan 17.
Xenobiotica. 2021.
PMID: 34983304
Item in Clipboard
Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System.
Yang R, Yin N, Zhao Y, Li D, Zhang X, Li X, Zhang Y, Faiola F.
Yang R, et al. Among authors: zhang x.
Front Pharmacol. 2022 Jan 3;12:772768. doi: 10.3389/fphar.2021.772768. eCollection 2021.
Front Pharmacol. 2022.
PMID: 35046808
Free PMC article.
Item in Clipboard
Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.
Kang N, Ma J, Hu Y, Di R, Wang L, Zhang X, Lai Y, Liu Y.
Kang N, et al. Among authors: zhang x.
Pharmaceuticals (Basel). 2024 Feb 23;17(3):291. doi: 10.3390/ph17030291.
Pharmaceuticals (Basel). 2024.
PMID: 38543077
Free PMC article.
Item in Clipboard
Cite
Cite